Panamera Holdings Corp. Files 2024 10-K

TL;DR

Panamera Holdings Corp. filed its 2024 10-K, detailing FY24 performance and risks. #investing

AI Summary

Panamera Holdings Corp. filed its 10-K for the fiscal year ending July 31, 2024, reporting on its management consulting services. The company's former name was Panamera Healthcare Corp, with a name change effective September 26, 2014. The filing details business operations, financial performance, and risk factors relevant to its industry.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Panamera Holdings Corp.'s financial health and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — The company operates in the management consulting services sector, which can be subject to economic fluctuations and competitive pressures.

Key Numbers

• $550,000,000 — Total Assets (Reported for fiscal year 2024)
• $50,000,000 — Total Liabilities (Reported for fiscal year 2024)

Key Players & Entities

• Panamera Holdings Corp. (company) — Filer of the 10-K
• 2024-07-31 (date) — Fiscal year end
• 8742 (number) — Standard Industrial Classification for Management Consulting Services
• NV (state) — State of incorporation
• 713-878-7200 (phone) — Business phone number
• Panamera Healthcare Corp (company) — Former company name
• 2014-09-26 (date) — Date of name change

FAQ

Key Financial Figures

• $0.0001 — Section 12(g) of the Act: Common Stock $0.0001 par value per share (Title of class)
• $8,333 — eld of Healthcare with a monthly fee of $8,333, with First DP Ventures, LP. The servic
• $66,667 — 4 and 2023, all discontinued revenue of $66,667 and $100,001 and as of July 31, 2024 an
• $100,001 — all discontinued revenue of $66,667 and $100,001 and as of July 31, 2024 and July 31, 20
• $0 — ly 31, 2023, the accounts receivable of $0 and $8,333 were derived from one custom
• $22,767,705 — erations, has an accumulated deficit of $22,767,705 and earned limited revenues of $19,643
• $19,643 — ,767,705 and earned limited revenues of $19,643 for the year ended July 31, 2024. With

Filing Documents

• pnht_10k.htm (10-K) — 956KB
• pnht_ex211.htm (EX-21.1) — 1KB
• pnht_ex311.htm (EX-31.1) — 11KB
• pnht_ex312.htm (EX-31.2) — 11KB
• pnht_ex321.htm (EX-32.1) — 5KB
• pnht_ex322.htm (EX-32.2) — 5KB
• pnht_10kimg1.jpg (GRAPHIC) — 6KB
• 0001640334-25-000065.txt ( ) — 4063KB
• pnht-20240731.xsd (EX-101.SCH) — 42KB
• pnht-20240731_lab.xml (EX-101.LAB) — 254KB
• pnht-20240731_cal.xml (EX-101.CAL) — 42KB
• pnht-20240731_pre.xml (EX-101.PRE) — 208KB
• pnht-20240731_def.xml (EX-101.DEF) — 89KB
• pnht_10k_htm.xml (XML) — 458KB

Forward-Looking Statements

Forward-Looking Statements 3 PART 1 Item 1.

Business

Business 5 Item 1A.

Risk Factors

Risk Factors 7 Item 1B. Unresolved Staff Comments 15 Item 1C. Cybersecurity 15 Item 2.

Properties

Properties 15 Item 3.

Legal Proceedings

Legal Proceedings 15 Item 4. Mine Safety Disclosures 15 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 16 Item 6. [Reserved] 17 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 21 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 21 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 21 Item 9A.

Controls and Procedures

Controls and Procedures 21 Item 9B. Other Information 23 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 23 PART III Item 10. Directors, Executive Officers and Corporate Governance 24 Item 11.

Executive Compensation

Executive Compensation 30 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 32 Item 13. Certain Relationships and Related Transactions, and Director Independence 33 Item 14. Principal Accounting Fees and Services 34 PART IV Item 15. Exhibits, Financial Statement Schedules 35 Item 16. Form 10-K Summary 35

Signatures

Signatures 36 2 Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This annual report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Report. These include the fact that: We require additional financing, and we may not be able to raise funds on favorable terms or at all, which raises questions about our ability to continue as a going concern; We have been and may continue to be negatively impacted by inflation; Because we have a limited operating history our future operations may not result in profitable operations; We rely on our management and if they were to leave our company our business plan could be adversely affected; Our operating results may fluctuate due to factors that are difficult to forecast and not within our control; Our executive officer controls a majority of our voting securities and therefore he has the ability to influence matters affecting our stockholders; We have identified material weaknesses in our disclosure controls and procedures and internal control over financial reporting; Because we are not subject to compliance with rules requiring the adoption of certain corporate governance measures, our s

BUSINESS

ITEM 1. BUSINESS General Overview Panamera Holdings Corporation ("Panamera" or the "Company") was incorporated under the laws of the State of Nevada on May 20, 2014, as Panamera Healthcare Corporation. On October 21, 2021, we changed our name to Panamera Holdings Corporation and increased the number of our authorized shares from 200,000,000 shares to 600,000,000 shares, par value $0.0001 per share, of which 550,000,000 were common stock and 50,000,000 were preferred stock. The Company originally intended to offer management and consulting services to healthcare organizations, but current management has redirected efforts now to pursuing business opportunities including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration. To date, the Company's activities have been limited to its formation and the raising of equity capital and providing consulting services to a healthcare company and activities in the scrap metal business.. Our Current Business We are currently seeking new business opportunities with established operating business entities to merge with or to acquire with our primary emphasis in the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration. In certain instances, a target business may wish to become our subsidiary, or may wish to contribute assets to us rather than merge with us. We have begun negotiations but not entered into any definitive agreements for potential new business opportunities, and there can be no assurance that we will be able to enter into any definitive agreements. Any new acquisition or business opportunities that we may acquire will require additional financing. There can be no assurance, however, that we will be able to acquire the financing necessary to enable us to pursue our plan of operation. If our Company requires additional financing and we a

RISK FACTORS

ITEM 1A. RISK FACTORS An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below as well as the other information in this filing before deciding to invest in our company. Any of the risk factors described below could significantly and adversely affect our business, prospects, financial condition and results of operations. Additional risks and uncertainties not currently known or that are currently considered to be immaterial may also materially and adversely affect our business, prospects, financial condition and results of operations. As a result, the trading price or value of our common stock could be materially adversely affected, and you may lose all or part of your investment. Risks Related to Our Business Operations : We require additional financing, and we may not be able to raise funds on favorable terms or at all, which raises questions about our ability to continue as a going concern. As of July 31, 2024, the Company has suffered recurring losses from operations, has an accumulated deficit of $22,767,705 and earned limited revenues of $19,643 for the year ended July 31, 2024. With our current cash on hand, expected revenues, and based on our current average monthly expenses, we currently anticipate the need for additional funding in order to continue our operations at their current levels and to pay the costs associated with being a public company for the next 12 months. We may also require additional funding in the future to expand or complete acquisitions. The most likely source of future funds presently available to us will be through the sale of equity capital and related party advances, provided that none are currently planned and no related parties are required to fund our operations. Any sale of share capital will result in dilution to existing stockholders. Furthermore, we may incur debt in the future, and may not have sufficient funds to repay our future indebtedness or may def

View Full Filing

View this 10-K filing on SEC EDGAR